Jefferies Financial Group Reiterates Buy Rating for ConvaTec Group (LON:CTEC)

ConvaTec Group (LON:CTEC)‘s stock had its “buy” rating reissued by equities researchers at Jefferies Financial Group in a research report issued to clients and investors on Friday,London Stock Exchange reports. They currently have a GBX 325 price objective on the stock. Jefferies Financial Group’s price objective would suggest a potential upside of 55.80% from the stock’s previous close.

Several other research analysts also recently weighed in on CTEC. Stifel Nicolaus restated a “buy” rating and issued a GBX 315 target price on shares of ConvaTec Group in a research note on Wednesday, March 11th. Citigroup reiterated an “outperform” rating and issued a GBX 315 price objective on shares of ConvaTec Group in a report on Thursday, March 5th. Deutsche Bank Aktiengesellschaft reissued a “buy” rating and issued a GBX 315 price objective on shares of ConvaTec Group in a research report on Wednesday, April 8th. Finally, Berenberg Bank restated a “buy” rating and set a GBX 340 target price on shares of ConvaTec Group in a research note on Tuesday, April 21st. Nine analysts have rated the stock with a Buy rating, According to data from MarketBeat.com, ConvaTec Group presently has an average rating of “Buy” and a consensus price target of GBX 319.67.

ConvaTec Group Stock Down 0.3%

LON:CTEC traded down GBX 0.60 during trading hours on Friday, hitting GBX 208.60. The stock had a trading volume of 64,630,465 shares, compared to its average volume of 37,529,566. The company has a market cap of £4.08 billion, a PE ratio of 24.26, a price-to-earnings-growth ratio of 0.93 and a beta of 0.78. The business has a 50 day simple moving average of GBX 224.81 and a two-hundred day simple moving average of GBX 232.05. ConvaTec Group has a 1-year low of GBX 199 and a 1-year high of GBX 311.20. The company has a current ratio of 1.53, a quick ratio of 0.96 and a debt-to-equity ratio of 106.19.

Insider Activity at ConvaTec Group

In other news, insider Jonny Mason sold 291,149 shares of the firm’s stock in a transaction that occurred on Monday, March 16th. The shares were sold at an average price of GBX 234, for a total transaction of £681,288.66. Company insiders own 0.95% of the company’s stock.

ConvaTec Group Company Profile

ConvaTec Group PLC engages in the development, manufacturing, and sale of medical products, services, and technologies in Europe, North America, and internationally. The company offers advanced wound dressings and skin care products for the management of acute and chronic wounds resulting from various conditions, such as diabetes, and acute conditions resulting from traumatic injury and burns. It also provides ostomy care solutions, including devices, accessories, and services for people with a stoma resulting from colorectal cancer, inflammatory bowel disease, and bladder cancer.